Sinovac vaccine may not trigger sufficient antibody response for the Brazilian variant: study
BEIJING (Reuters) – Sinovac Biotech’s COVID-19 vaccine may not trigger sufficient antibody responses against a new variant identified in Brazil, a small-sample laboratory study showed.T…
